FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a method of selecting a stable antibody producing under the control of a CMV promoter of a human with SEQ ID NO: 1 Chinese hamster ovary CHO-K1 cells.
EFFECT: disclosed method of selecting antibody-producing cells based on determination of histone 3 acetylation level and cpG-site methylation frequency in position 425 in SEQ ID NO: 1 enables reducing the number of clones to be tested during cultivation of several generations.
7 cl, 28 dwg, 20 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
EXPRESSION VECTOR ELEMENT COMBINATION, NEW METHODS FOR OBTAINING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2012 |
|
RU2639519C2 |
COMBINATIONS OF EXPRESSION VECTOR ELEMENTS, NEW METHODS FOR PRODUCING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2012 |
|
RU2756910C2 |
NUCLEIC ACID SEQUENCE ENCODING HIV-1 GAG PROTEIN, METHOD FOR ITS PREPARING, VECTOR CONTAINING THEREOF, PROTEIN ENCODED BY ITS, PHARMACEUTICAL COMPOSITION AND THEIR USING IN PROPHYLAXIS AND/OR TREATMENT OF HIV-INFECTION AND AIDS | 2002 |
|
RU2312896C2 |
METHOD OF PRODUCING POLYPEPTIDES | 2015 |
|
RU2699715C2 |
RECOMBINANT PLASMID DNA PBIPR-ABIGA1FI6-HT FOR OBTAINING RECOMBINANT IMMUNOGLOBULIN A IGOTH IGA1 | 2016 |
|
RU2656142C1 |
RECOMBINANT PLASMID DNA OF pBiPr-ABIgA2m1F16-ht TO OBTAIN RECOMBINANT IMMUNOGLOBULIN A OF ISOTYPE IgA2m1 | 2016 |
|
RU2671477C2 |
RECOMBINANT PLASMID DNA pBiIPr-ABIgA1FI6-INTHT FOR OBTAINING RECOMBINANT IGA1 ISOTYPE IMMUNOGLOBULIN | 2016 |
|
RU2664184C2 |
METHOD FOR PRODUCING RECOMBINANT IGA2m1 ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2022 |
|
RU2801178C1 |
METHOD OF PRODUCING DIMERIC FORM OF IMMUNOGLOBULIN IGA1-ISOTYPE IN MAMMALIAN CELLS | 2023 |
|
RU2822890C1 |
METHOD OF PRODUCING DIMERIC FORM OF MUTANT IGA2M1-ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2023 |
|
RU2822889C1 |
Authors
Dates
2019-11-27—Published
2015-05-13—Filed